The largest hospital for infectious diseases and COVID-19 patients, the modular Leishenshan Hospital was created with "China Speed," surprising the world with its 14-day construction.
CSADI and Dassault Systèmes are using the 3DEXPERIENCE platform's simulation capabilities to simulate virus contamination and diffusion within the hospital's ventilation system and to counteract the negative effects from unplanned ventilation risks.
As a strategic partner of Dassault Systèmes in China, CSADI undertook the design of Leishenshan Hospital. Avoiding contamination of nearby environments is a key consideration for CSADI, especially the minimisation of cross-infection in the hospital and any impacts on external communities, crowds and surroundings.
To this end, Dassault Systèmes has donated SIMULIA XFlow software, powered by the 3DEXPERIENCE platform, to CSADI to simulate indoor and outdoor fluids, virus dispersal in ventilation systems, as well as other projects within Leishenshan Hospital.
Dassault Systèmes provide business and people with collaborative 3D virtual environments to imagine sustainable innovations.
SCG Cell's SCG101V therapy Investigational New Drug Application receives Chinese regulatory approval
INOVIO prices USD25m public offering
Blacksmith Medicines granted US patent for antibacterial compounds targeting LpxC
Seegene launches STAgora infectious disease analytics platform
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Oxurion signs LOI to acquire majority stake in preclinical microbiology CRO
bioMérieux acquires Day Zero Diagnostics assets to expand rapid sequencing diagnostics
EDX Medical and Spire Healthcare sign strategic diagnostic partnership agreement
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
Ondine's Steriwave proven effective against deadly Mucor fungus
Mycovia Pharmaceuticals reports first participant enrolled in Phase 2 cryptococcal meningitis study
bioMérieux launches rapid PCR test for equine respiratory diseases
Ondine Biomedical joins CAN Health Network to advance Steriwave adoption in Canada
Seegene presrnts CURECA conceptual video at ESCMID Global 2025